ArticleIrish journal of medical science2026

Dordaviprone-the first and only approved treatment option for recurrent H3 K27M-mutant diffuse midline glioma - Letter to the editor.

Laiba Bibi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.